跳至主要内容
临床试验/CTRI/2020/10/028731
CTRI/2020/10/028731已完成3 期

Higher vs. Lower Doses of Dexamethasone in Patients with COVID-19 and Severe Hypoxia - COVID STEROID 2 trial

Professor Anders Perner0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • All the following criteria must be fulfilled:
  • Aged 18 years or above AND
  • Confirmed SARS-CoV-2(COVID-19) requiring hospitalisation AND
  • Use of one of the following:
  • Invasive mechanical ventilation OR
  • Non-invasive ventilation or continuous use of continuous positive airway pressure (CPAP) for hypoxia OR
  • Oxygen supplementation with an oxygen flow of at least 10 L/min independent of delivery system

排除标准

  • Use of systemic corticosteroids for other indications than COVID-19 in doses higher than 6 mg dexamethasone equivalents
  • Use of systemic corticosteroids for COVID-19 for 5 consecutive days or more
  • Invasive fungal infection
  • ctive tuberculosis
  • Fertile woman ( <60 years of age) with positive urine human gonadotropin (hCG) or plasma-hCG
  • Known hypersensitivity to dexamethasone
  • Previously randomised into the COVID STEROID 2 trial
  • Informed consent not obtainable

研究者

发起方
Professor Anders Perner

相似试验